3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
17
Prostatic Neoplasms
12
Lung Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
5
Prostatic Neoplasms, Castration-Resistant
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Endometrial Neoplasms
4
Neoplasms
3
Breast Neoplasms
3
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Salivary Gland Neoplasms
2
Oropharyngeal Neoplasms
2
Non-Muscle Invasive Bladder Neoplasms
2
Neoplasm Metastasis
2
Nasopharyngeal Carcinoma
2
Lymphoid Interstitial Pneumonia
2
Carcinoma, Transitional Cell
2
Carcinoma
2
Anatomic Stage II Breast Cancer AJCC v8
2
Anatomic Stage I Breast Cancer AJCC v8
2
Uterine Neoplasms
1
Urothelial Cancer
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Selected Subjects With Advanced Solid Tumors
1
Interventions
durvalumab
2
Tretinoin
2
Paclitaxel
2
Carboplatin
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
talazoparib
1
sarilumab
1
pexidartinib
1
pertuzumab
1
pembrolizumab
1
patritumab
1
olaparib
1
niraparib
1
neratinib
1
ganitumab
1
dostarlimab
1
cemiplimab
1
abemaciclib
1
Trastuzumab
1
Standard of Care
1
STA 9090
1
SGN-LIV1A
1
Pemetrexed
1
MK 2206
1
Letrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
Docetaxel
×
30 days
×
Clear all
No trials found.